Background Long-term mental and physical health consequences of COVID-19 (long
COVID) are a persistent public health concern. Little is still known about the long-term …

Background An important but often insufficient aspect of care in people with inflammatory
arthritis (IA) is empowering patients to acquire a good understanding of their disease and …

Rheumatoid arthritis (RA) is a serious disorder of the joints affecting 1 or 2% of the
population aged between 20 and 50 years worldwide. RA is the foremost cause of disability …

Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation that
involves symmetric polyarthritis of small and large joints. Autoimmune rheumatic diseases …

Depression is common in patients with rheumatoid arthritis (RA); however, the precise
mechanisms underlying a link between depression and RA remain unclear. Accumulating …

During the coronavirus disease-2019 (COVID-19) pandemic there were several barriers to
treatment access and medication adherence in rheumatoid arthritis (RA) patients. There is …

Nationwide lockdowns during SARS-CoV-2 (COVID-19) can compromise mental health and
psychological wellbeing and limit opportunities for physical activity (PA), particularly in …

Differences in clinical presentation, response to treatment, and long-term outcomes between
autoantibody-positive and-negative rheumatoid arthritis (RA) highlight the need for a better …

Coping with a chronic disease such as rheumatoid arthritis (RA) involves significant
changes in life and promotes stressful situations. The inability to cope with stress can …

G-protein coupled receptor (GPCR) kinases (GRKs) and hypoxia-inducible factor-1α (HIF-
1α) play key roles in rheumatoid arthritis (RA). Several studies have demonstrated that HIF …